OC METRO CALENDAR

  • December 2014
    SuMoTuWeThFrSa
    30123456
    78910111213
    14151617181920
    21222324252627
    28293031123
    45678910
Add an event

MEDICAL BREAKTHROUGHS
Untitled Page Published: May 20, 2009 02:10 AM



Masimo, continued ...

However, conventional two-wavelength pulse oximeters are incapable of measuring carboxyhemoglobin and methemoglobin levels, thus they cannot provide clinicians with an accurate picture of true oxygenation status in the presence of dyshemoglobins.

Masimo Rainbow SET-the first-and-only technology that continuously and noninvasively measures SpCO and SpMet, in addition to total hemoglobin (SpHb), oxygen content (SpOC), PVI, oxyhemoglobin (SpO2), pulse rate and PI.

This allows for faster and more accurate assessment of the patient's true oxygenation, which may help to advance the care and management of patients with sickle cell disease.

"This research not only reinforces the clinical accuracy of SpCO and SpMet in assessing the true oxygenation of patients, but also highlights the importance of measuring these dyshemoglobins while managing and treating pediatric patients with sickle cell disease," says Dr. Michael O’Reilly, executive vice president of Medical Affairs for Masimo.

<< PREVIOUS PAGE

Related headlines
Huntington Beach’s Impact Medical rebrands as iTech Medical
AMDL of Tustin seals deal for cancer distribution
Costa Mesa's Oxygen Biotherapeutics inks deal with U.S. Navy
UC Irvine banks $45 million for infectious disease research
NIH: Masimo's SpCO may guage asthma severity in kids